Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-aminobutyric acid type A receptor subunit (GABA(_A_) receptor subunit) refers to any member of a family of protein subunits that assemble to form the pentameric GABA(_A_) receptor, the primary mediator of fast inhibitory neurotransmission in the mammalian central nervous system. Nineteen different subunit genes have been identified (six α, three β, three γ, three ρ, and one each of δ, ε, π, θ), and most native receptors are composed of two α, two β, and one γ or δ subunit. These heteropentameric complexes form ligand-gated chloride ion channels which respond to the neurotransmitter GABA to hyperpolarize neurons, suppressing action potential generation. Subunit composition confers specific pharmacological and physiological properties, explaining the varying sensitivity of receptor subtypes to drugs such as benzodiazepines, barbiturates, neurosteroids, and anesthetics. Dysfunction or alteration in subunit composition and expression is implicated in a wide spectrum of CNS pathologies, making GABA(_A_) receptor subunits key therapeutic targets for epilepsy, anxiety, insomnia, and related neurological and psychiatric conditions[1][2][3][4][5][6][7].\n\n**Note:** The entry "GABA(_A_) receptor subunits" is not itself a single canonical target but a *group* of related molecules—specifically, a family of receptor subunits. Each individual GABA(_A_) subunit (such as "Gamma-aminobutyric acid type A receptor subunit alpha-1") has distinct properties, and a single, unified entry should specify the precise subunit or receptor isoform for structured analysis. Thus, "GABA(_A_) receptor subunits" is too broad and non-specific for structured data entry; a canonical entry should refer to the full receptor (e.g., "Gamma-aminobutyric acid type A receptor") or a specific subunit (e.g., "Gamma-aminobutyric acid type A receptor subunit alpha-1")[1][4][5][6].
Allosteric modulation (positive or negative), Direct agonism/antagonism at GABA binding site, Channel blockade
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor subunit (GABA(_A_) receptor subunit).